Lp(a)HORIZON: BILM’s position on the first Lp(a) outcomes trial
The British Institute for Longevity Medicine responds to Lp(a)HORIZON: what the neutral pelacarsen trial shows, what it leaves open and what BILM advises.
The British Institute for Longevity Medicine responds to Lp(a)HORIZON: what the neutral pelacarsen trial shows, what it leaves open and what BILM advises.